Throwing money at an already heated market looks nonsensical and could lose the Treasury £2bn Surprise, surprise. Presented, or so they thought, with an end-March deadline to save a few thousand pounds on stamp duty, buyers rushed to complete their house purchases. Mortgage lending in… Read More »Sunak’s stamp duty holiday extension has merely inflamed the housing market
Covid crisis spurs growing interest in drugmakers, diagnostics and medical equipment firms UK drugmakers, diagnostics, medical equipment and other life sciences companies have raised £10.6bn from private funding rounds and stock market flotations in the first three months of the year, more than half of… Read More »Investors flock to life sciences as UK sector breaks funding record
The five life sciences IPOs this week continues the steady march companies are making to the public markets this year. This week’s activity follows a first quarter that Renaissance Capital calculates was the busiest for newly public companies since 2000. Healthcare IPOs continued to dominate… Read More »Biotech and medical device companies raise $913M in a five-IPO week
Vaccitech, the Oxford-based firm behind the AstraZeneca vaccine, is a high-profile float that slipped away A glowing, Deliveroo-style tribute from Rishi Sunak will not be required for this flotation. Vaccitech, the Oxford-based firm that owns some of the key biotechnology behind the AstraZeneca Covid vaccine,… Read More »A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay
Healthcare technology companies raised a record of $15.3 billion in 2020, according to a report from Silicon Valley Bank. For the first time, digital health companies surpassed biopharma for the number of deals.